Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab

Stefan Diem(University of St.Gallen), Sabine Schmid(University of St.Gallen), M. Krapf(University of Bern), Lukas Flatz(University of St.Gallen), Diana Born(University of St.Gallen), Wolfram Jochum(University of St.Gallen), Arnoud J. Templeton(St. Claraspital), Martin Früh(University of St.Gallen)
Lung Cancer
July 24, 2017
Cited by 1,018

Abstract


Related Papers

No related papers found

Powered by citation graph analysis